Are RSV shots next in line for restrictions in the US?

Are RSV shots next in line for restrictions in the US?

[ad_1] After pushing for restrictions on vaccines for COVID-19 and hepatitis B, the Trump administration seems to be turning its attention to recently approved shots that protect infants against respiratory syncytial virus (RSV). According to a Reuters report, the FDA has launched an investigation into the safety of antibody-based preventative medicines – Sanofi/AstraZeneca’s Beyfortus (nirsevimab)…

Read More
Malaria’s Comeback in the U.S. | Johns Hopkins

Malaria’s Comeback in the U.S. | Johns Hopkins

[ad_1] For the first time in 20 years, the U.S. has recorded homegrown malaria cases. The country sees about 2,000–2,500 malaria cases each year linked to travel to malaria-endemic areas such as sub-Saharan Africa and parts of South America and Southeast Asia—but the nine locally transmitted cases seen so far this year were contracted by…

Read More
Kennedy sharpens vaccine attacks, without scientific backing

Kennedy sharpens vaccine attacks, without scientific backing

[ad_1] As the federal government prepares for the next meeting of its Advisory Committee on Immunization Practices, Health and Human Services Secretary Robert F. Kennedy Jr. has intensified his attacks on aluminum vaccine components used in many shots to boost the body’s immune response. Kennedy, a longtime anti-vaccine activist before seeking public office, claims that…

Read More
New NIH grant supports development of experimental pediatric HIV vaccine

New NIH grant supports development of experimental pediatric HIV vaccine

[ad_1] A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. A successful vaccine to prevent new HIV infections would be a…

Read More